Literature DB >> 7921753

Polynesian women are also at risk for hyperuricaemia and gout because of a genetic defect in renal urate handling.

H A Simmonds1, M B McBride, P J Hatfield, R Graham, J McCaskey, M Jackson.   

Abstract

The prevalence of asymptomatic hyperuricaemia among Polynesian women (Maoris, Cook Islanders, Samoans, Tongans) was high--44%. This hyperuricaemia resulted from a reduced fractional uric acid clearance (FEur: uric acid clearance factored by creatinine clearance x 100--6.7 +/- 1.5%) compared with the FEur in healthy UK women (12.8 +/- 2.9%). This reduction in FEur was not as great as that in young UK women with familial juvenile hyperuricaemic nephropathy (FJHN: 5.1 +/- 1.5%) and was not associated with impaired renal function. The FEur in the normouricaemic Polynesians (9.7 +/- 1.9%) was also lower than that in healthy UK women (12.8 +/- 2.9%). The reduced FEur in these Polynesian women supports the hypothesis that indigenous Pacific races share a similar genetic defect in renal urate handling to that reported as the basis for the susceptibility to hyperuricaemia in Maori men. Neither alcohol nor hypertension contributed to this. This study also confirmed that, compared with their European counterparts, Polynesian women have a high purine intake and a strong tendency to obesity which increases with age. These factors, together with the reduced FEur, put them at added risk for gout. However, the reduction in FEur was not as great as that reported for the normouricaemic or asymptomatic hyperuricaemic Maori male (4.9 +/- 1.5% and 3.9 +/- 1.4%, respectively), confirming the same sex difference in renal urate handling in adult Polynesians as in caucasians.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7921753     DOI: 10.1093/rheumatology/33.10.932

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  16 in total

Review 1.  Diagnosis and management of gout: a rational approach.

Authors:  E Suresh
Journal:  Postgrad Med J       Date:  2005-09       Impact factor: 2.401

2.  Characterization of a recurrent in-frame UMOD indel mutation causing late-onset autosomal dominant end-stage renal failure.

Authors:  Graham D Smith; Caroline Robinson; Andrew P Stewart; Emily L Edwards; Hannah I Karet; Anthony G W Norden; Richard N Sandford; Fiona E Karet Frankl
Journal:  Clin J Am Soc Nephrol       Date:  2011-10-27       Impact factor: 8.237

3.  Population-Specific Resequencing Associates the ATP-Binding Cassette Subfamily C Member 4 Gene With Gout in New Zealand Māori and Pacific Men.

Authors:  Callum Tanner; James Boocock; Eli A Stahl; Amanda Dobbyn; Asim K Mandal; Murray Cadzow; Amanda J Phipps-Green; Ruth K Topless; Jennie Harré Hindmarsh; Lisa K Stamp; Nicola Dalbeth; Hyon K Choi; David B Mount; Tony R Merriman
Journal:  Arthritis Rheumatol       Date:  2017-05-31       Impact factor: 10.995

4.  Familial renal disease or familial juvenile hyperuricaemic nephropathy?

Authors:  M B McBride; H A Simmonds; F Moro
Journal:  J Inherit Metab Dis       Date:  1997-07       Impact factor: 4.982

5.  Mendelian randomization analysis associates increased serum urate, due to genetic variation in uric acid transporters, with improved renal function.

Authors:  Kim Hughes; Tanya Flynn; Janak de Zoysa; Nicola Dalbeth; Tony R Merriman
Journal:  Kidney Int       Date:  2013-09-18       Impact factor: 10.612

6.  The experience and impact of gout in Māori and Pacific people: a prospective observational study.

Authors:  Nicola Dalbeth; Meaghan E House; Anne Horne; Leanne Te Karu; Keith J Petrie; Fiona M McQueen; William J Taylor
Journal:  Clin Rheumatol       Date:  2012-11-01       Impact factor: 2.980

Review 7.  Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes?

Authors:  Richard J Johnson; Santos E Perez-Pozo; Yuri Y Sautin; Jacek Manitius; Laura Gabriela Sanchez-Lozada; Daniel I Feig; Mohamed Shafiu; Mark Segal; Richard J Glassock; Michiko Shimada; Carlos Roncal; Takahiko Nakagawa
Journal:  Endocr Rev       Date:  2009-01-16       Impact factor: 19.871

8.  The renal urate transporter SLC17A1 locus: confirmation of association with gout.

Authors:  Jade E Hollis-Moffatt; Amanda J Phipps-Green; Brett Chapman; Gregory T Jones; Andre van Rij; Peter J Gow; Andrew A Harrison; John Highton; Peter B Jones; Grant W Montgomery; Lisa K Stamp; Nicola Dalbeth; Tony R Merriman
Journal:  Arthritis Res Ther       Date:  2012-04-27       Impact factor: 5.156

Review 9.  New developments in the epidemiology and genetics of gout.

Authors:  Raihana Zaka; Charlene J Williams
Journal:  Curr Rheumatol Rep       Date:  2006-06       Impact factor: 4.686

10.  Fractional clearance of urate: validation of measurement in spot-urine samples in healthy subjects and gouty patients.

Authors:  Diluk R W Kannangara; Sheena N Ramasamy; Praveen L Indraratna; Sophie L Stocker; Garry G Graham; Graham Jones; Ian Portek; Kenneth M Williams; Richard O Day
Journal:  Arthritis Res Ther       Date:  2012-08-17       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.